Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy.

BMC Res Notes · 2012 · PMC3412754 · PMID 22621282

Europe PMC DOI

hedged sentence

0.0002

closest p · 0.0× alpha

0.0002

boldest claim

The sentences

highly significantp < 0.0002actually significant

When the tumour volumes at day 4 post-treatment were compared to untreated tumour volumes at day 4, there were highly significant differences (p < 0.0002) at all doses (Table 1 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.